Matches in Wikidata for { <http://www.wikidata.org/entity/Q64123349> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q64123349 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q64123349 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64123349 description "scientific article published on 16 July 2018" @default.
- Q64123349 description "wetenschappelijk artikel" @default.
- Q64123349 description "наукова стаття, опублікована у 2018" @default.
- Q64123349 description "գիտական հոդված հրատարակված 2018 թվականի հուլիսի 16-ին" @default.
- Q64123349 name "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 name "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 type Item @default.
- Q64123349 label "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 label "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 prefLabel "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 prefLabel "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 P1433 Q64123349-132F6A7C-F082-4172-B4EE-5162DB7CE0D6 @default.
- Q64123349 P1476 Q64123349-37F5F169-6B82-46B5-99E5-37B804FBFB6A @default.
- Q64123349 P2093 Q64123349-205A3FCB-ECDC-4325-A506-D5C6AF8DBC1F @default.
- Q64123349 P2093 Q64123349-25E00E80-F1D0-4F86-B00B-6058D5D24DA1 @default.
- Q64123349 P2093 Q64123349-28248A73-8C22-44A8-BB6B-604E9552B805 @default.
- Q64123349 P2093 Q64123349-29EE524F-131D-4993-8C57-2F84D99A3A58 @default.
- Q64123349 P2093 Q64123349-47EA2C83-9995-49EA-9F74-608971A13ED6 @default.
- Q64123349 P2093 Q64123349-6631AC9A-39B9-47DE-BA14-E6C28CDE532D @default.
- Q64123349 P2093 Q64123349-7208795B-DC64-4263-B763-22EC7DDFDEE2 @default.
- Q64123349 P2093 Q64123349-75F7D7EE-F01A-4D07-A1CC-52568E9DF3CF @default.
- Q64123349 P2093 Q64123349-80FD4A0B-A559-4A96-B235-62A5E0ED6B35 @default.
- Q64123349 P2093 Q64123349-81A24EFB-CA13-452B-BEF2-3EB19747CDED @default.
- Q64123349 P2093 Q64123349-85B6AA46-3965-4027-9B9F-7823A8246ED2 @default.
- Q64123349 P2093 Q64123349-AB43D199-E692-45BB-B5C6-E5B3812E4FD6 @default.
- Q64123349 P2093 Q64123349-B3D02BD6-79FA-4FB0-93B5-075CB8A667C1 @default.
- Q64123349 P2093 Q64123349-B61239B3-2D05-450B-8FB3-AB61876DA794 @default.
- Q64123349 P2093 Q64123349-FBC058E4-96C1-476A-93A4-3A5AE90F5760 @default.
- Q64123349 P2093 Q64123349-FDDE87E5-8DF2-4EEA-8045-58FC4C6A9D19 @default.
- Q64123349 P275 Q64123349-69134b35-1cbe-4534-877a-aac33392d4e9 @default.
- Q64123349 P304 Q64123349-87937044-EB78-4CBD-AE3F-863D034EB18C @default.
- Q64123349 P31 Q64123349-77ECB9D4-32D4-4604-BEF1-587C4E34B583 @default.
- Q64123349 P31 Q64123349-DDB80872-0524-4D17-94B4-9946BB5C7271 @default.
- Q64123349 P356 Q64123349-C03B86E3-D7C7-45D3-BBEB-D3798BF66EAC @default.
- Q64123349 P407 Q64123349-CD7859E8-F517-445F-98A6-D68CD5521F3F @default.
- Q64123349 P478 Q64123349-09ADA1C9-84C8-4CA8-AABE-BC4C6EDAB6A4 @default.
- Q64123349 P50 Q64123349-C315243C-F8D5-4A95-ACD3-3BC9EDC06931 @default.
- Q64123349 P577 Q64123349-E9BFD6F2-C148-4E21-8C66-92C70BA95B44 @default.
- Q64123349 P6216 Q64123349-6cd9b6ef-e182-462e-bda8-a411c02f405a @default.
- Q64123349 P698 Q64123349-6FF8938F-FAB2-40BE-8BE9-BED00C3AA8C2 @default.
- Q64123349 P921 Q64123349-63FB2891-9423-444C-98DC-B42C598DFCB2 @default.
- Q64123349 P921 Q64123349-B025655B-E013-4A1F-B9B2-FBAA7BE5767F @default.
- Q64123349 P921 Q64123349-F69F033F-2D1D-4E9D-ACE8-6AC3DB368A74 @default.
- Q64123349 P932 Q64123349-78F50FD3-ADE6-4BAE-81D2-C02F935A2862 @default.
- Q64123349 P356 FIMMU.2018.01641 @default.
- Q64123349 P698 30046297 @default.
- Q64123349 P1433 Q27723748 @default.
- Q64123349 P1476 "Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931" @default.
- Q64123349 P2093 "Andrew L Gilman" @default.
- Q64123349 P2093 "Arlene Naranjo" @default.
- Q64123349 P2093 "Barry L Shulkin" @default.
- Q64123349 P2093 "C Patrick Reynolds" @default.
- Q64123349 P2093 "John M Maris" @default.
- Q64123349 P2093 "Julie R Park" @default.
- Q64123349 P2093 "Karen S Messer" @default.
- Q64123349 P2093 "L Mary Smith" @default.
- Q64123349 P2093 "M Fevzi Ozkaynak" @default.
- Q64123349 P2093 "Malcolm Smith" @default.
- Q64123349 P2093 "Marguerite Parisi" @default.
- Q64123349 P2093 "Mitchell B Diccianni" @default.
- Q64123349 P2093 "Paul M Sondel" @default.
- Q64123349 P2093 "Robert Seeger" @default.
- Q64123349 P2093 "Sheena C Tenney" @default.
- Q64123349 P2093 "Wendy B London" @default.
- Q64123349 P275 Q20007257 @default.
- Q64123349 P304 "1641" @default.
- Q64123349 P31 Q13442814 @default.
- Q64123349 P31 Q1348305 @default.
- Q64123349 P356 "10.3389/FIMMU.2018.01641" @default.
- Q64123349 P407 Q1860 @default.
- Q64123349 P478 "9" @default.
- Q64123349 P50 Q56989429 @default.
- Q64123349 P577 "2018-07-16T00:00:00Z" @default.
- Q64123349 P6216 Q50423863 @default.
- Q64123349 P698 "30046297" @default.
- Q64123349 P921 Q1427096 @default.
- Q64123349 P921 Q55501991 @default.
- Q64123349 P921 Q938205 @default.
- Q64123349 P932 "6055015" @default.